Skip to main content
Top
Published in: Reactions Weekly 1/2017

01-06-2017 | Case report

Cisplatin/gemcitabine

Neutropenia: case report

Published in: Reactions Weekly | Issue 1/2017

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Cho MH, et al. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review. World Journal of Surgical Oncology 14: 270, No. 1, 20 Oct 2016. Available from: URL: http://doi.org/10.1186/s12957-016-1021-3 - SouthKorea Cho MH, et al. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review. World Journal of Surgical Oncology 14: 270, No. 1, 20 Oct 2016. Available from: URL: http://​doi.​org/​10.​1186/​s12957-016-1021-3 - SouthKorea
Metadata
Title
Cisplatin/gemcitabine
Neutropenia: case report
Publication date
01-06-2017
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31479-7

Other articles of this Issue 1/2017

Reactions Weekly 1/2017 Go to the issue

Case report

Lansoprazole